Edwards Lifesciences Corp (NYSE:EW)

CAPS Rating: 4 out of 5

A global provider of products and technologies designed to treat advanced cardiovascular disease. The Company focuses on specific cardiovascular opportunities including heart valve disease, peripheral vascular disease and critical care technologies.


Player Avatar TrackRonBaron (92.11) Submitted: 2/20/2008 4:49:36 PM : Outperform Start Price: $24.66 EW Score: +358.99

Ron Baron owns 5204400 shares of Edwards Lifesciences Corp.. As of September 30th, 2007 EW was up 33.87% over the last quarter, composed 1.27% of his portfolio, and he controlled 9.18% of the company.

Featured Broker Partners